RxDoctor Payments Data

Marvin Morrison, APRN

Nurse Practitioner · East Carbon, UTNPI 1043599004

Payments from drug & device makers

$988in general payments, 2019–2025

Across 57 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$601
  • Gilead$69
  • AstraZeneca$59
  • Alkermes, Inc.$49
  • Boehringer Ingelheim$48
  • Neurocrine Biosciences, Inc.$25
  • plus $139 from 8 others

What the payments were for

  • Food & beverage$988100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$988 in reported general payments places this provider in the 75th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Medicare billing

Part B allowed, 2024
$1,212
Medicare patients
44
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin39$51,393
MounjaroTirzepatide29$43,607
TrulicityDulaglutide35$41,491
XareltoRivaroxaban14$22,856
OzempicSemaglutide15$16,738
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl19$3,527
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine52$1,615
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$949
Gabapentin37$805
Celecoxib34$777
Atorvastatin Calcium81$660
Rosuvastatin Calcium87$659
Lisinopril70$559
Quetiapine Fumarate13$544
Albuterol Sulfate HfaAlbuterol Sulfate30$517

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$48$51,39339 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 979 nurse practitioner providers in Utah.

Other nurse practitioner in East Carbon

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →